Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Venous thromboembolism is a frequent and potentially life-threatening complication of orthopedic surgery. Rivaroxaban is an oral direct factor Xa inhibitor, which was shown to be effective for the prevention of venous thromboembolism after elective hip and knee arthroplasty in the RECORD study progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Turpie, Alexander GG, Schmidt, André C, Kreutz, Reinhold, Lassen, Michael R, Jamal, Waheed, Mantovani, Lorenzo, Haas, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373318/
https://www.ncbi.nlm.nih.gov/pubmed/22701330
http://dx.doi.org/10.2147/VHRM.S30064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373318/
https://www.ncbi.nlm.nih.gov/pubmed/22701330
http://dx.doi.org/10.2147/VHRM.S30064

Ejemplares similares